
Carmustine Cuts Alzheimer’s Plaque by 75% in Mice
Florida researchers noticed that people with cancer tended not to get Alzheimer’s disease. So, FDA approved anti-cancer drugs were screened to see how well they

Florida researchers noticed that people with cancer tended not to get Alzheimer’s disease. So, FDA approved anti-cancer drugs were screened to see how well they

Amlodipine, an inexpensive drug approved for high blood pressure, could become the first ever treatment for vascular dementia. Vascular dementia is one of the most

New research shows that the Alzheimer’s drug memantine (Namenda™) may treat Huntington’s dementia. It seems to improve motor learning and coordination, as well as keep cells alive. It appears to work in a way that could also benefit dementia in traumatic brain injury and some forms of stroke. Can memantine offer a multi-type dementia breakthrough?

A proven approach to slow the aging process and associated diseases is dietary restriction. New research helps explain the action of a drug that appears

Research has shown that the Parkinson’s drug, rasagiline, could be a viable therapeutic option for people with Alzheimer’s disease. Learn about the new effort to

Pramlintide (known by the brand name Symlin®, an FDA-approved diabetic drug) reduces Alzheimer’s amyloid-beta peptides in the lab. Learn how it improves learning and memory.

VIDEO & IN-DEPTH ARTICLE The largest fine in the history of prescribing antipsychotic drugs to dementia patients was handed down by The Department of Justice.

VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic

Using Deep Brain Stimulation to treat Alzheimer’s is starting to take off. More patients are being added to clinical trials. Learn about the U.S. FDA’s

News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

Strengthening social connections may offer a surprising boost to long-term brain health.

When Memory Loss Becomes Invisible to Those Who Need Help Most

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


